Soleno Therapeutics, Inc.

SLNONASDAQHealthcare

$53.01

+$0.00(+0.00%)

Market Cap$2.8B

P/E Ratio—

52W High$90.3199

52W Low$29.43

Avg Volume3.4M

Open$52.99

Beta-2.22

Net Income Financials Revenue

Soleno Therapeutics, Inc. (SLNO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

SLNO · net income · updated Jun 9, 2026

Core profitability metrics

SLNO · net income · margin · TTM · CAGR

Net income was $20.9M for FY2025 (fiscal year ending 2025-12-31), up 111.9% year-over-year. Net profit margin was 11.0%. Based on available data, Soleno Therapeutics, Inc. has been profitable since at least 2025.

FY2025 Net Income$20.9M▲ +111.9% YoY

Trailing 12M (TTM)$96.0Mtrailing 4 quarters sum

Net Profit Margin11.0%$20.9M ÷ $190.4M

YoY Change+111.9%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2025

▸ FMP /income-statement · Annual · SLNO net income history · SLNO profit margin

Annual net income data

SLNO · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025★ First Profit$20.9M▲ +111.9%11.0%$190.4M

FY2024Loss−$175.8M▼ 351.0%—$0

FY2023Loss−$39.0M▼ 62.0%—$0

FY2022Loss−$24.1M▲ +22.1%—$0

FY2021Loss−$30.9M▼ 25.5%—$0

Net income vs peers (Healthcare)

SLNO vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Soleno Therapeutics, Inc.YOU

SLNO

$20.9M+111.9%11.0%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Soleno Therapeutics, Inc. (SLNO) reported net income of $20.9M for FY2025 (fiscal year ending 2025-12-31), up 111.9% year-over-year. The net profit margin was 11.0% — meaning the company kept $0.11 of every dollar of revenue as profit.

Based on available data, Soleno Therapeutics, Inc. has been profitable since at least 2025. Net income reached a peak of $20.9M in FY2025. Data available for 14 fiscal years.

Soleno Therapeutics, Inc.'s net profit margin was 11.0% for FY2025, based on the latest annual results.

Investors sometimes search for "Soleno Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from SLNO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

SLNO net income · 5 questions

Soleno Therapeutics, Inc. is profitable. The company reported net income of $20.9M for FY2025, a net profit margin of 11.0%. Net income was up 111.9% year-over-year. Based on available data, Soleno Therapeutics, Inc. has been profitable since at least 2025.

is SLNO profitabledoes SLNO make a profitSLNO profitabilitySLNO profitable company

▸ Source: FMP /income-statement · GAAP · Soleno Therapeutics, Inc. · Soleno Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026